Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07125391) titled 'Chemotherapy Combined With Propranolol Hydrochloride as Neoadjuvant Therapy for Advanced High-grade Serous Ovarian Cancer' on Aug. 9.

Study Type: Interventional

Study Design: Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Bai-Rong Xia

Condition: Ovarian Cancer

Intervention: Drug: Cohort A

Recruitment Status: Recruiting

Phase: Phase 2

Date of First Enrollment: June 20, 2025

Target Sample Size: 40

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/ct2/show/NCT07125391

Published by ...